IR Overview
FluoroPharma Medical, Inc. (OTCQB: FPMI)FluoroPharma Medical, Inc. (FPMI) engages in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD). Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, amyloid plaque in Alzheimer’s disease and agents for detection of certain types of cancer. Quick Links
Recent News |
Share StatisticsOutstanding: 22,440,894 Company InformationFluoroPharma Medical, Inc. 8 Hillside Ave Management TeamDavid R. Elmaleh, PhD Thijs Spoor Boyan Goumnerov, MD |
Investor RelationsThijs Spoor |
Transfer AgentHolladay Stock Transfer |
AuditorsMartinelliMick PLLC |